Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Feb 19:11:614993.
doi: 10.3389/fendo.2020.614993. eCollection 2020.

A Sensitive Plasma Insulin Immunoassay to Establish the Diagnosis of Congenital Hyperinsulinism

Affiliations
Observational Study

A Sensitive Plasma Insulin Immunoassay to Establish the Diagnosis of Congenital Hyperinsulinism

Julie Siersbæk et al. Front Endocrinol (Lausanne). .

Abstract

Background: The diagnosis of congenital hyperinsulinism (CHI) may be hampered by a plasma (p-) insulin detection limit of 12-18 pmol/L (2-3 mU/L).

Objective: To evaluate the diagnostic performance of a sensitive insulin immunoassay and to find the optimal p-insulin cut-off for the diagnosis of CHI.

Methods: Diagnostic fasting tests, performed without medication or i.v.-glucose, were investigated in children with a clinical diagnosis of CHI, or idiopathic ketotic hypoglycemia (IKH). The CHI diagnosis was either clinical or by the alternative, p-insulin-free criteria; hypoglycemia plus disease-causing genetic mutations and/or CHI-compatible pancreatic histopathology. We included diagnostic p-insulin samples with simultaneous p-glucose <3.2 mmol/L and used a sensitive insulin assay (Cobas e411 immunoassay analyzer; lower detection limit 1.2 pmol/L; normal range 15.1-147.1 pmol/L). Receiver operating characteristics area under the curve (ROC AUC) values and optimal cut-offs were analyzed for the performance of p-insulin to diagnose CHI.

Results: In 61 CHI patients, the median (range) p-insulin was 76.5 (17-644) pmol/L compared to 1.5 (1.5-7.7) pmol/L in IKH patients (n=15). The ROC AUC was 1.0 for the diagnosis of CHI defined both by the clinical diagnosis (n=61) and by alternative criteria (n=57). The optimal p-insulin cut-offs were 12.3 pmol/L, and 10.6 pmol/L, at p-glucose <3.2 mmol/L (n=61), and <3.0 mmol/L (n=49), respectively.

Conclusions: The sensitive insulin assay performed excellent in diagnosing CHI with optimal p-insulin cut-offs at 12.3 pmol/L (2.0 mU/L), and 10.6 pmol/L (1.8 mU/L), at p-glucose <3.2 mmol/L, and <3.0 mmol/L, respectively. A sensitive insulin assay may serve to simplify the diagnosis of CHI.

Keywords: children; congenital hyperinsulinism; diagnostic performance; hypoglycemia; immunoassays.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Patient inclusion flowchart. CHI, congenital hyperinsulinism; IKH, idiopathic ketotic hypoglycemia; p, plasma.
Figure 2
Figure 2
Two-way scatter-plot showing the association between p-insulin and p-glucose, split by IKH and subtypes of CHI. The X-axis is in logarithmic scale. Gray area indicates the normal insulin reference range 15.1–147.1 pmol/L for normal fasting glucose concentrations. +, IKH; ◆ and ◇, diffuse CHI; • and ○, focal CHI; Δ, atypical CHI; □, CHI with unknown histology. Closed symbols, KATP-channel mutations. Open symbols, no KATP -channel mutations.
Figure 3
Figure 3
ROC-curves performed for the four predefined groups including cut-offs and 95% CI. Critical samples of p-insulin when simultaneous p-glucose was <3.2 mmol/L or <3.0 mmol/L. Alternative diagnosis of CHI was based on p-insulin free criteria.

References

    1. Galcheva S, Al-Khawaga S, Hussain K. Diagnosis and management of hyperinsulinaemic hypoglycaemia. Best Pract Res Clin Endocrinol Metab (2018) 32(4):551–73. 10.1016/j.beem.2018.05.014 - DOI - PubMed
    1. Stanley CA. Perspective on the Genetics and Diagnosis of Congenital Hyperinsulinism Disorders. J Clin Endocrinol Metab (2016) 101(3):815–26. 10.1210/jc.2015-3651 - DOI - PMC - PubMed
    1. de Lonlay P, Fournet JC, Touati G, Groos MS, Martin D, Sevin C, et al. . Heterogeneity of persistent hyperinsulinaemic hypoglycaemia. A series of 175 cases. Eur J Pediatr (2002) 161(1):37–48. 10.1007/s004310100847 - DOI - PubMed
    1. Shah P, Rahman SA, Demirbilek H, Guemes M, Hussain K. Hyperinsulinaemic hypoglycaemia in children and adults. Lancet Diabetes Endocrinol (2017) 5(9):729–42. 10.1016/S2213-8587(16)30323-0 - DOI - PubMed
    1. Menni F, de Lonlay P, Sevin C, Touati G, Peigne C, Barbier V, et al. . Neurologic outcomes of 90 neonates and infants with persistent hyperinsulinemic hypoglycemia. Pediatrics (2001) 107(3):476–9. 10.1542/peds.107.3.476 - DOI - PubMed

Publication types